CYP7A1 and hepatocellular carcinoma: In conclusion, our study demonstrates that in Abcb4−/− mice FXR activation by long-term administration of INT-767 stimulates FGF15 production, thereby repressing hepatic Cyp7a1 expression, and ultimately leading to endogenous BA reduction and to HCC prevention.